• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征女性心血管风险评估和心血管疾病预防:雄激素过多和多囊卵巢综合征(AE-PCOS)学会的共识声明。

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.

机构信息

Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.

出版信息

J Clin Endocrinol Metab. 2010 May;95(5):2038-49. doi: 10.1210/jc.2009-2724. Epub 2010 Apr 7.

DOI:10.1210/jc.2009-2724
PMID:20375205
Abstract

OBJECTIVE

Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD.

PARTICIPANTS

An expert panel in PCOS and CVD reviewed literature and presented recommendations.

EVIDENCE

Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third.

CONSENSUS PROCESS

Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board.

CONCLUSIONS

Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist.

摘要

目的

患有多囊卵巢综合征(PCOS)的女性通常存在心血管疾病(CVD)风险因素。雄激素过多和多囊卵巢综合征(AE-PCOS)学会成立了一个专家组,对评估 PCOS-CVD 风险关系的研究进行了循证综述,并制定了预防 CVD 的指南。

参与者

PCOS 和 CVD 方面的专家小组审查了文献并提出了建议。

证据

仅纳入了比较 PCOS 与对照患者的研究。所有电子数据库均进行了搜索;综述包括了单独的研究/数据库、系统综述、摘要和专家数据。如果未排除其他高雄激素紊乱、PCOS 诊断不明确、未描述对照或方法学排除评估,则排除了这些文章。纳入/排除标准由至少两名评审员确认,并由第三名评审员仲裁。

共识过程

对 CVD 风险因素的系统综述进行了汇编,并提交给 AE-PCOS 学会理事会批准。

结论

患有肥胖症、吸烟、血脂异常、高血压、糖耐量受损和亚临床血管疾病的 PCOS 女性存在风险,而患有代谢综合征和/或 2 型糖尿病的女性则存在 CVD 高风险。建议对所有患有 PCOS 的女性进行体重指数、腰围、血清脂质/葡萄糖和血压测定,对肥胖、年龄较大、个人有妊娠糖尿病史或家族有 2 型糖尿病史的女性建议进行口服葡萄糖耐量试验。建议对所有 PCOS 患者进行情绪障碍评估。建议进行生活方式管理,以预防 CVD 为主要目标,针对低密度脂蛋白和非高密度脂蛋白胆固醇,如果血脂异常或其他危险因素持续存在,则添加胰岛素增敏剂和其他药物。

相似文献

1
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.多囊卵巢综合征女性心血管风险评估和心血管疾病预防:雄激素过多和多囊卵巢综合征(AE-PCOS)学会的共识声明。
J Clin Endocrinol Metab. 2010 May;95(5):2038-49. doi: 10.1210/jc.2009-2724. Epub 2010 Apr 7.
2
Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.多囊卵巢综合征育龄妇女2型糖尿病和心血管疾病风险概况的综合评估:一项大型加拿大队列研究
J Obstet Gynaecol Can. 2019 Oct;41(10):1453-1460. doi: 10.1016/j.jogc.2018.11.026. Epub 2019 Feb 1.
3
Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?多囊卵巢综合征中的 2 型糖尿病和心血管疾病:风险有哪些,能否降低?
Diabet Med. 2010 May;27(5):498-515. doi: 10.1111/j.1464-5491.2010.02994.x.
4
Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome.多囊卵巢综合征患者内脏肥胖和心血管风险的标志物。
Eur J Obstet Gynecol Reprod Biol. 2012 Oct;164(2):161-6. doi: 10.1016/j.ejogrb.2012.05.037. Epub 2012 Jun 23.
5
Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.多囊卵巢综合征(PCOS)女性随着年龄增长出现排卵周期,改变了心血管和代谢危险因素的轨迹。
Hum Reprod. 2013 Aug;28(8):2245-52. doi: 10.1093/humrep/det119. Epub 2013 Apr 17.
6
Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.患有多囊卵巢综合征的超重女性有亚临床心血管疾病的证据。
J Clin Endocrinol Metab. 2005 Oct;90(10):5711-6. doi: 10.1210/jc.2005-0011. Epub 2005 Jul 26.
7
High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).印度患有多囊卵巢综合征(PCOS)的青春期女性的高敏C反应蛋白(hs-CRP)水平及其与多囊卵巢综合征各组分的关系。
Gynecol Endocrinol. 2014 Nov;30(11):781-4. doi: 10.3109/09513590.2014.924099. Epub 2014 Aug 19.
8
Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications.多囊卵巢综合征与慢性炎症:药物治疗的意义。
Ann Pharmacother. 2012 Mar;46(3):403-18. doi: 10.1345/aph.1Q514. Epub 2012 Feb 28.
9
Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.动脉僵硬度在无症状非糖尿病绝经后多囊卵巢综合征表型女性中增加。
J Hypertens. 2013 Oct;31(10):1998-2004. doi: 10.1097/HJH.0b013e3283630362.
10
Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.载脂蛋白 A-I 和 B 水平、血脂异常和代谢综合征与中国西南部多囊卵巢综合征妇女。
Hum Reprod. 2012 Aug;27(8):2484-93. doi: 10.1093/humrep/des191. Epub 2012 Jun 6.

引用本文的文献

1
Exploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study.探索1400种血浆代谢物与多囊卵巢综合征:一项双向孟德尔随机化研究
Brain Behav. 2025 Aug;15(8):e70745. doi: 10.1002/brb3.70745.
2
Exogenous estradiol increases cardiovagal baroreflex sensitivity during a hypertensive stimulus in premenopausal young women.外源性雌二醇可提高绝经前年轻女性在高血压刺激期间的心血管迷走性压力反射敏感性。
Am J Physiol Heart Circ Physiol. 2025 Aug 1;329(2):H439-H449. doi: 10.1152/ajpheart.00131.2025. Epub 2025 Jul 3.
3
Beneficial Effects of Alchemilla vulgaris in DHEA-Induced Rat Model of Polycystic Ovary Syndrome.
伏地委陵菜对脱氢表雄酮诱导的多囊卵巢综合征大鼠模型的有益作用。
Reprod Sci. 2025 Jul;32(7):2453-2466. doi: 10.1007/s43032-025-01885-9. Epub 2025 Jun 23.
4
The role of sex differences in cardiovascular, metabolic, and immune functions in health and disease: a review for "Sex Differences in Health Awareness Day".性别差异在健康与疾病状态下心血管、代谢及免疫功能中的作用:为“健康意识日之性别差异”所做的综述
Biol Sex Differ. 2025 May 13;16(1):33. doi: 10.1186/s13293-025-00714-7.
5
Distribution of polycystic ovary syndrome (PCOS) phenotypes in Iranian women: a cross-sectional study.伊朗女性多囊卵巢综合征(PCOS)表型的分布:一项横断面研究。
BMC Res Notes. 2025 May 13;18(1):215. doi: 10.1186/s13104-025-07202-6.
6
Association of dietary phytochemical index with metabolic markers, serum asymmetric dimethylarginine and atherogenic indices in patients with polycystic ovary syndrome.多囊卵巢综合征患者饮食植物化学物质指数与代谢指标、血清不对称二甲基精氨酸及致动脉粥样硬化指数的关联
Nutr Metab (Lond). 2025 May 7;22(1):39. doi: 10.1186/s12986-025-00932-1.
7
Neuroendocrine mechanisms responsible for elevated gonadotrophin-releasing hormone and luteinising hormone pulses in polycystic ovary syndrome.多囊卵巢综合征中导致促性腺激素释放激素和促黄体生成素脉冲升高的神经内分泌机制。
J Neuroendocrinol. 2025 Apr 18:e70028. doi: 10.1111/jne.70028.
8
The Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications-A Narrative Review.多囊卵巢综合征的分子基础及其心脏代谢相关性:探索交叉点及其临床意义——一篇叙述性综述
Biomedicines. 2025 Mar 13;13(3):709. doi: 10.3390/biomedicines13030709.
9
Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches.心脏代谢疾病中的性别二态性:从发育到衰老及治疗方法
Cells. 2025 Mar 20;14(6):467. doi: 10.3390/cells14060467.
10
Measures of Serum Markers HbA1c, HOMA-IR, HOMA-β, QUICKI and G/I Ratio as Predictors of Abnormal Glucose Tolerance Among Thai Women with Polycystic Ovary Syndrome.血清标志物糖化血红蛋白(HbA1c)、胰岛素抵抗指数(HOMA-IR)、胰岛β细胞功能指数(HOMA-β)、定量胰岛素敏感性检测指数(QUICKI)和血糖/胰岛素比值(G/I比值)作为泰国多囊卵巢综合征女性糖耐量异常预测指标的研究
J Clin Med. 2025 Feb 21;14(5):1452. doi: 10.3390/jcm14051452.